IL4 and rheumatoid arthritis: In RA, IL-4 can inhibit growth factor-induced synovial cell proliferation by interfering with the cell cycle and reducing cell survival and can exert antiangiogenic effects by inhibiting the production of vascular endothelial growth factor in FLSs [158–161].